About Zaltanpharma
Zaltanpharma is a Healthcare company based in Las Rozas De Madrid (Spain) founded in 2017, and was acquired by RIEMSER Pharma in October 2019. Diversified drugs are distributed by Zaltanpharma in Spain. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Cofares, Hefame and ATP Farma.
Company details
Zaltanpharma was established in 2017 in Las Rozas De Madrid, Spain. Operations are focused on the distribution of diversified drugs within the pharmaceutical sector. A range of pharmaceutical products is handled through supply chain services to various markets. The companys domain, zaltanpharma.com, supports its online activities. Geographic presence is centered in Spain, with emphasis on regulatory compliance in drug distribution.
- Headquarters Las Rozas De Madrid, Spain
- Stage Acquired
- SectorsHealthcare
- Website zaltanpharma.com
- Acquired by RIEMSER Pharma (Oct 2019)
- Investors
- Acquired byRIEMSER Pharma
(Oct 2019)
Investors in Zaltanpharma
Zaltanpharma has secured backing from 1 investor. Prominent investors backing the company include RIEMSER Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Contract development and manufacturing services for pharmaceutical APIs are provided. | 2000 | riemser.com | Greifswald, Germany |
Investor details for Zaltanpharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zaltanpharma
2 dated milestones of Zaltanpharma across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Zaltanpharma is founded.
- Exit Acquired by RIEMSER Pharma.
Competitors of Zaltanpharma
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cofares.es | 1944 | Madrid, Spain | Pharmaceutical cooperative offering logistics and support for Spanish pharmacies and labs. | |||
| hefame.es | 1951 | Santomera, Spain | Offers pharmacy management, health training, and community support services. | |||
| atp-farma.com | 2005 | Madrid, Spain | Consumer healthcare products are distributed and developed by ATP Farma. |
Detailed competitors of Zaltanpharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zaltanpharma
Complete news archive for Zaltanpharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zaltanpharma
Zaltanpharma was founded in 2017.
Zaltanpharma is headquartered in Las Rozas De Madrid, Spain. It is registered at Las Rozas De Madrid, Community Of Madrid, Spain.
Zaltanpharma was established in 2017 in Las Rozas De Madrid, Spain. Operations are focused on the distribution of diversified drugs within the pharmaceutical sector. A range of pharmaceutical products is handled through supply chain services to various markets. The companys domain, zaltanpharma.com, supports its online activities. Geographic presence is centered in Spain, with emphasis on regulatory compliance in drug distribution.
Zaltanpharma has 1 investor. Key investors include RIEMSER Pharma.
Yes. Zaltanpharma was acquired by RIEMSER Pharma in October 2019.